BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9916557)

  • 1. A new approach to monitoring anticoagulation therapy: testing prothrombin time at home.
    Harv Heart Lett; 1999 Jan; 9(5):2-4. PubMed ID: 9916557
    [No Abstract]   [Full Text] [Related]  

  • 2. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Question: In adult patients on warfarin, does-home-self-testing of prothrombin time and/or international normalized ratio provide the same outcomes compared to testing by a home health nurse or in a clinical setting?
    Heu MK; Welborn T; Nagykaldi Z
    J Okla State Med Assoc; 2016 Mar; 109(3):99-100. PubMed ID: 27265957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial gives nod to home warfarin monitoring.
    Harv Heart Lett; 2009 Feb; 19(6):6. PubMed ID: 19579310
    [No Abstract]   [Full Text] [Related]  

  • 6. Self-monitoring for patients on warfarin?
    Drug Ther Bull; 2009 Sep; 47(9):98-101. PubMed ID: 19734191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home anticoagulation monitoring is safe and effective.
    Harv Heart Lett; 2000 Dec; 11(4):4-5. PubMed ID: 11114792
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical inquiries. What is the interval for monitoring warfarin therapy once therapeutic levels have been achieved?
    Meurer LN; Jamieson B; Guthmann R
    J Fam Pract; 2005 Feb; 54(2):171-2. PubMed ID: 15689295
    [No Abstract]   [Full Text] [Related]  

  • 9. MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy.
    Albrecht R
    Manag Care Q; 2006; 14(1):13-6. PubMed ID: 17590971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.
    Wittkowsky AK; Sekreta CM; Nutescu EA; Ansell J
    Pharmacotherapy; 2005 Feb; 25(2):265-9. PubMed ID: 15767240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin therapy: tips and tools for better control.
    Garcia DA; Schwartz MJ
    J Fam Pract; 2011 Feb; 60(2):70-5. PubMed ID: 21301641
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-testing and self-management of warfarin anticoagulation therapy in geriatric patients.
    Pugh AN; Murphy BL
    Consult Pharm; 2013 May; 28(5):319-21. PubMed ID: 23649681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
    Davidson SJ; Turner N; Tillyer L
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):707-8. PubMed ID: 20885134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'carry-over' effects of patient self-testing: positive effects on usual care management by an anticoagulation management service.
    Ryan F; O'Shea S; Byrne S
    Thromb Res; 2010 Nov; 126(5):e345-8. PubMed ID: 20828796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Self testing and self management of oral anticoagulants with warfarin].
    Nadav L; Schwartz J
    Harefuah; 2003 Sep; 142(8-9):621-3, 645, 644. PubMed ID: 14518167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation.
    Khan TI; Kamali F; Kesteven P; Avery P; Wynne H
    Br J Haematol; 2004 Aug; 126(4):557-64. PubMed ID: 15287950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.